共 50 条
- [31] De-escalation towards omission is the tipping point of individualizing breast cancer surgery EJSO, 2020, 46 (08): : 1543 - 1545
- [34] De-Escalating Breast or Low-Risk Ductal Carcinoma in Situ JAMA ONCOLOGY, 2020, 6 (07) : 1117 - 1118
- [36] De-escalating systemic chemotherapy might be considered for pure triple negative apocrine breast cancer patients JOURNAL OF BUON, 2019, 24 (02): : 864 - 864